Bill to limit hydrocodone access wins broad Congressional support

Bipartisan bills introduced Wednesday in both houses of Congress propose tightening access to hydrocodone painkillers such as Vicodin.

Within a day, 42 cosponsors from both parties had stepped forward to support the legislation, according to The Hill. These lawmakers believe that changing hydrocodone from a Schedule III to a Schedule II drug will combat the growing problem of prescription drug addiction and abuse. Opponents of the measure, including some workers in nursing homes and other healthcare providers, say the reclassification will just make it harder to care for people in pain.

Earlier this month, legislators received a letter from the Food and Drug Administration saying that the standard reclassification process would be lengthy, and making the change through legislation would be faster. An FDA panel had previously recommended the change to Schedule II, and lawmakers had pressed the agency to act on that quickly.

If the bill passes, people will no longer be able to refill hydrocodone prescriptions by fax or phone, and long-term care operators might have to store the medication differently.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.